hirly

Klinikum der Universität München

Postdoctoral Researcher – CAR T-Cell Development and Tumor Immunology (m/w/d)

München, Bayern, Germany

hirly Pro

Get in front of the people hiring at Klinikum der Universität München

  • Reach the hiring manager at Klinikum der Universität München on LinkedIn, from your own account
  • hirly applies to this job for you, with unlimited applications
  • A resume and cover letter written for this job, unlimited
  • The hiring manager and recruiter at Klinikum der Universität München, with contact details
Get Pro for this job →

$49 a month · ₹1,999 for 30 days in India · cancel any time

See how you match this job — and similar ones. Free.

Upload your resume and hirly scores it against this role at Klinikum der Universität München first, then against similar open jobs, and shows where you fit and why.

PDF or DOCX, up to 12MB. No sign-up to see your matches.

Get past the screening software and onto a recruiter's desk

hirly rewrites your resume for this job — matching the keywords and skills in the posting, moving your most relevant experience to the top, and writing a cover letter to fit. About 30 seconds.

  • Keywords matched to this posting
  • Fit score before you apply
  • Cover letter included

Matched against 2.2M live jobs from 220,000+ employers in 200+ countries.

Tailor my resume for this job →

Apply from your AI assistant

Connect hirly to Claude or ChatGPT and ask it to apply to this job. hirly tailors your resume, fills the employer’s form and asks before sending.

Some employer sites stop an application at a CAPTCHA or sign-in and hand it back with a link. Applying needs a paid plan. Works with any assistant that supports MCP.

hirly's read of this role

Role family
Healthcare
Seniority
Mid level
Country
DE
Work mode
On-site / unstated
First seen by hirly
19 Nov 2026

Derived automatically from the posting. Upload your resume above to see how the role scores against it.

the posting

Scope of duties

  • · Develop and optimize CAR constructs and support their transfer into a scalable retroviral vector system
  • · Generate and characterize CAR T cells and assess their functionality in vitro using AML cell lines and primary patient samples
  • · Investigate CAR T-cell cytotoxicity, activation, differentiation, and proliferation.
  • · Evaluate potential off-target effects and hematopoietic toxicity using humanized mouse models and healthy human tissue explant models
  • · Analyze experimental data, document results, and contribute to scientific publications and preclinical safety evaluation
  • · Collaborate with interdisciplinary research teams within the CARAMeL consortium

Our requirements

· PhD, MD, PharmD, DVM, or an equivalent doctoral degree in immunology, molecular or cell biology, biochemistry, biomedical sciences, or a related field

  • · Strong experimental research experience and a good publication record
  • · Solid knowledge of immunology and cell biology, with practical experience in cell culture and functional assays
  • · Experience in one or more of the following areas is highly desirable: CAR T-cell engineering, viral vector technology, flow cytometry, or preclinical in vivo models
  • · Strong analytical skills and an independent, structured approach to research
  • · High motivation, initiative, and the ability to work collaboratively in an international research environment
  • · Excellent written and spoken English

Our offer

  • · Contract duration: 2 years fixed-term
  • · The Institute of Clinical Pharmacology at LMU University Hospital Munich offers an interdisciplinary research environment at the interface of experimental immunology, innovative cell therapies, and translational medicine
  • · The research group of Prof. Dr. Sebastian Kobold focuses on developing novel cancer immunotherapies, particularly cellular therapies and antibody-based approaches
  • · This position is part of the CARAMeL consortium, funded by the German Cancer Consortium (DKTK). The project aims to advance an innovative CAR T-cell therapy for patients with relapsed or refractory acute myeloid leukemia (AML). A key objective is to improve therapeutic efficacy while minimizing damage to healthy hematopoietic stem and progenitor cells
  • · The successful candidate will contribute to translating the CAR technology into a scalable retroviral vector system and investigating the functionality and preclinical safety of the resulting CAR T cells. The work will be conducted in close collaboration with national and international research partners
Original posting on Klinikum der Universität München's site ↗

Listed on hirly, a job board. hirly is not the employer: Klinikum der Universität München is hiring for this role.

Want this one?

Upload your resume and hirly rewrites it for this job and writes the cover letter — in about thirty seconds, before you sign up.

Tailor my resume for this job